Document: New product information wording - Extracts from PRAC recommendations on signals adopted at the 9-12 March 2026 PRAC-2026/4/7

Document: PRAC recommendations on signals adopted at the 9-12 March 2026 PRAC meeting-2026/4/7

Document: List of signals discussed at PRAC since September 2012-2026/4/7

Page: Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline-2026/4/1

Page: Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline-2026/4/1

Document: Minutes of the COMP meeting 17-19 February 2026-2026/4/1

Document: Records of data processing activity for the Union Product Database-2026/4/1

Document: European Medicines Agency’s data protection notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise-2026/4/1

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 March 2026-2026/4/1

Page: Medicines for human use under evaluation-2026/4/1